Innovative linkers, connecting antibodies to payloads, are fine-tuning ADC selectivity while broadening their therapeutic scope.

Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.

Moderna has announced the expansion of its US manufacturing capabilities with the onshoring of drug product manufacture to Massachusetts.

Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication to its label and offering a more convenient dosing option, as the drugmaker ...

Novartis' two new sites in North Carolina fall under the Swiss pharma’s $23bn US manufacturing onshoring ploy.

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...

Mesenchymal stem cells have been explored across a wide range of diseases due to their potential to reduce inflammation and promote tissue repair and regeneration.

Roche has conditional marketing authorisation from the EC for Lunsumio SC for adults with R/R FL after at least two systemic therapies.